Qube Research & Technologies (QRT)
INZY

Qube Research & Technologies (QRT)’s Inozyme Pharma INZY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,006
Closed -$72.8K – 3743
2025
Q1 		$72.8K Buy
+80,006
New +$111K ﹤0.01% 3057
2024
Q3 		– Sell
-10,765
Closed -$48K – 3706
2024
Q2 		$48K Buy
+10,765
New +$52.2K ﹤0.01% 2753

Other funds holding INZY

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INZY Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 80,006 shares — an estimated $72.8K sold.

Qube Research & Technologies (QRT) first reported a position in INZY in Q2 2024 and held it in 2 quarters. The position peaked at $72.8K in Q1 2025. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 80,006 Inozyme Pharma shares in Q2 2025, an estimated $72.8K.
  • Qube Research & Technologies (QRT) first reported a position in Inozyme Pharma in Q2 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Inozyme Pharma position peaked at $72.8K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.